Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Am J Med Genet A ; 188(1): 71-82, 2022 01.
Article in English | MEDLINE | ID: covidwho-1427048

ABSTRACT

The coronavirus pandemic increased anxiety and stress and prevented access to health care worldwide; it is unclear how COVID-19 affected adults with a multisystem genetic disorder such as neurofibromatosis (NF). An anonymous online survey was distributed through an international registry and foundations to adults with NF (June-August 2020) to assess the impact of the pandemic on mental health and NF health care. Six hundred and thirteen adults (18-81 years; M = 45.7) with NF1 (77.8%), NF2 (14.2%), and schwannomatosis (7.8%) provided complete responses. Respondents rated moderate-to-high amounts of worry about the impact of COVID-19 on their emotional (46.3%) and physical health (46.7%), and 54.8% endorsed moderate-to-high pandemic-related stress. Adults with diagnosed/suspected mental health disorders or moderate-to-severe NF symptom impact as well as females endorsed higher COVID-19 stress (ps < 0.01). Less than half who missed a doctor's appointment for their NF care (43.4%) used telehealth. Of these, 33.3% and 46.2% reported that telehealth met their needs to a moderate or high degree, respectively. Results indicated that subgroups of adults with NF experience higher COVID-19-related worries and stress and may need additional support. Furthermore, telehealth is under-utilized and could help NF providers connect with patients, although improved delivery and patient training may facilitate expanded use of these services.


Subject(s)
Anxiety/psychology , COVID-19/psychology , Mental Health/statistics & numerical data , Neurofibromatoses/psychology , Stress, Psychological/physiopathology , Telemedicine/statistics & numerical data , Adolescent , Adult , Aged , Aged, 80 and over , Anxiety/physiopathology , COVID-19/epidemiology , Europe/epidemiology , Female , Humans , Male , Middle Aged , Neurofibromatoses/physiopathology , SARS-CoV-2/pathogenicity , Surveys and Questionnaires , United States/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL